These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 38856220

  • 1. Identification of a copper-responsive small molecule inhibitor of uropathogenic Escherichia coli.
    Hanson BS, Hailemariam A, Yang Y, Mohamed F, Donati GL, Baker D, Sacchettini J, Cai JJ, Subashchandrabose S.
    J Bacteriol; 2024 Jul 25; 206(7):e0011224. PubMed ID: 38856220
    [Abstract] [Full Text] [Related]

  • 2. Antibiotic Resistance Among Uropathogenic Escherichia coli.
    Kot B.
    Pol J Microbiol; 2019 Dec 25; 68(4):403-415. PubMed ID: 31880885
    [Abstract] [Full Text] [Related]

  • 3. The inner membrane protein YhiM links copper and CpxAR envelope stress responses in uropathogenic E. coli.
    Saenkham-Huntsinger P, Ritter M, Donati GL, Mitchell AM, Subashchandrabose S.
    mBio; 2024 Apr 10; 15(4):e0352223. PubMed ID: 38470052
    [Abstract] [Full Text] [Related]

  • 4. Plant phenolics inhibit focal adhesion kinase and suppress host cell invasion by uropathogenic Escherichia coli.
    Lewis AJ, Richards AC, Mendez AA, Dhakal BK, Jones TA, Sundsbak JL, Eto DS, Rousek AA, Mulvey MA.
    Infect Immun; 2024 May 07; 92(5):e0008024. PubMed ID: 38534100
    [Abstract] [Full Text] [Related]

  • 5. Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea.
    Lee JH, Subhadra B, Son YJ, Kim DH, Park HS, Kim JM, Koo SH, Oh MH, Kim HJ, Choi CH.
    Lett Appl Microbiol; 2016 Jan 07; 62(1):84-90. PubMed ID: 26518617
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of fluoroquinolone-resistant and broad-spectrum cephalosporin-resistant community-acquired urinary tract infections in Rio de Janeiro: Impact of Escherichia coli genotypes ST69 and ST131.
    de Souza da-Silva AP, de Sousa VS, de Araújo Longo LG, Caldera S, Baltazar ICL, Bonelli RR, Santoro-Lopes G, Riley LW, Moreira BM.
    Infect Genet Evol; 2020 Nov 07; 85():104452. PubMed ID: 32634601
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Virulence factors of uropathogenic Escherichia coli (UPEC) and correlation with antimicrobial resistance.
    Shah C, Baral R, Bartaula B, Shrestha LB.
    BMC Microbiol; 2019 Sep 02; 19(1):204. PubMed ID: 31477018
    [Abstract] [Full Text] [Related]

  • 10. CpxA Phosphatase Inhibitor Activates CpxRA and Is a Potential Treatment for Uropathogenic Escherichia coli in a Murine Model of Infection.
    Fortney KR, Smith SN, van Rensburg JJ, Brothwell JA, Gardner JJ, Katz BP, Ahsan N, Duerfeldt AS, Mobley HLT, Spinola SM.
    Microbiol Spectr; 2022 Apr 27; 10(2):e0243021. PubMed ID: 35297652
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Redox-Mediated Inactivation of the Transcriptional Repressor RcrR is Responsible for Uropathogenic Escherichia coli's Increased Resistance to Reactive Chlorine Species.
    Sultana S, Crompton ME, Meurer K, Jankiewicz O, Morales GH, Johnson C, Horbach E, Hoffmann KP, Kr P, Shah R, Anderson GM, Mortimer NT, Schmitz JE, Hadjifrangiskou M, Foti A, Dahl JU.
    mBio; 2022 Oct 26; 13(5):e0192622. PubMed ID: 36073817
    [Abstract] [Full Text] [Related]

  • 14. Copper primes adaptation of uropathogenic Escherichia coli to superoxide stress by activating superoxide dismutases.
    Saenkham P, Ritter M, Donati GL, Subashchandrabose S.
    PLoS Pathog; 2020 Aug 26; 16(8):e1008856. PubMed ID: 32845936
    [Abstract] [Full Text] [Related]

  • 15. Peptidoglycan endopeptidase MepM of uropathogenic Escherichia coli contributes to competitive fitness during urinary tract infections.
    Huang WC, Dwija IBNP, Hashimoto M, Wu JJ, Wang MC, Kao CY, Lin WH, Wang S, Teng CH.
    BMC Microbiol; 2024 May 30; 24(1):190. PubMed ID: 38816687
    [Abstract] [Full Text] [Related]

  • 16. Uropathogenic Escherichia coli virulence characteristics and antimicrobial resistance amongst pediatric urinary tract infections.
    Alfuraiji N, Al-Hamami A, Ibrahim M, Rajab HK, Hussain BW.
    J Med Life; 2022 May 30; 15(5):650-654. PubMed ID: 35815089
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of adhesin genes and risk factors associated with urinary tract infections by drug-resistant uropathogenic Escherichia coli in North of Iran.
    Sheikhi R, Amini ME, Alidoust L, Atrkar Roushan Z, Nikokar I.
    J Infect Dev Ctries; 2024 May 30; 18(5):761-769. PubMed ID: 38865401
    [Abstract] [Full Text] [Related]

  • 18. A novel chaperone-effector-immunity system identified in uropathogenic Escherichia coli UMN026.
    Casiano González A, Pacheco Villanueva A, Castro-Alarcón N, Méndez J, Oropeza R, Martínez-Santos VI.
    PeerJ; 2024 May 30; 12():e17336. PubMed ID: 38784397
    [Abstract] [Full Text] [Related]

  • 19. Extended spectrum β-lactamase producing uropathogenic Escherichia coli and the correlation of biofilm with antibiotics resistance in Nepal.
    Shrestha R, Khanal S, Poudel P, Khadayat K, Ghaju S, Bhandari A, Lekhak S, Pant ND, Sharma M, Marasini BP.
    Ann Clin Microbiol Antimicrob; 2019 Dec 17; 18(1):42. PubMed ID: 31847837
    [Abstract] [Full Text] [Related]

  • 20. Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice.
    Guiton PS, Cusumano CK, Kline KA, Dodson KW, Han Z, Janetka JW, Henderson JP, Caparon MG, Hultgren SJ.
    Antimicrob Agents Chemother; 2012 Sep 17; 56(9):4738-45. PubMed ID: 22733070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.